DURECT Corp (DRRX) Misses Q3 EPS by 1c

DURECT Corp (NASDAQ: DRRX) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.26 million versus the consensus estimate of $4.1 million.

For earnings history and earnings-related data on DURECT Corp (DRRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat